STOCK-BASED COMPENSATION (Details 1) |
3 Months Ended |
|---|---|
|
Mar. 31, 2025
$ / shares
shares
| |
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
| Restricted Stock Units, Beginning balance | 55,110,881 |
| Restricted Stock Units, Ending balance | 55,110,881 |
| Equity Classified [Member] | Restricted Stock Units (RSUs) [Member] | |
| Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
| Restricted Stock Units, Beginning balance | 6,526 |
| Restricted Stock Units, Granted | 19,584 |
| Restricted Stock Units, Vested | (19,584) |
| Restricted Stock Units, Ending balance | 6,526 |
| Weighted average grant date fair value | $ / shares | $ 0.73 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|